Hepatic Decompensation and Serious Adverse Events in Liver Transplant Recipients Treated with Sofosbuvir-containing Regimens for Recurrent HCV Infection

被引:0
|
作者
Patel, Neal M. [1 ]
Bichoupan, Kian [1 ]
Ku, Lawrence [1 ]
Yalamanchili, Rachana [1 ]
Harty, Alyson [1 ]
Gardenier, Donald [1 ]
Ng, Michel [1 ]
Motamed, David B. [1 ]
Khaitova, Viktoriya [1 ]
Bach, Nancy [1 ]
Chang, Charissa Y. [1 ]
Grewal, Priya [1 ]
Bansal, Meena B. [1 ]
Agarwal, Ritu [1 ]
Liu, Lawrence [1 ]
Im, Gene Y. [1 ]
Leong, Jennifer [1 ]
Kim-Schluger, Leona [1 ]
Odin, Joseph A. [1 ]
Ahmad, Jawad [1 ]
Friedman, Scott L. [1 ]
Dieterich, Douglas [1 ]
Schiano, Thomas D. [1 ]
Perumalswami, Ponni V. [1 ]
Branch, Andrea D. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Liver Dis, Parsippany, NJ USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1185
引用
收藏
页码:795A / 796A
页数:2
相关论文
共 50 条
  • [1] High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens
    Perumalswami, P. V.
    Patel, N.
    Bichoupan, K.
    Ku, L.
    Yalamanchili, R.
    Harty, A.
    Motamed, D.
    Khaitova, V.
    Chang, C.
    Grewal, P.
    Liu, L.
    Schiano, T. D.
    Woodward, M.
    Dieterich, D. T.
    Branch, A. D.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2016, 23 (09) : 667 - 676
  • [2] Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
    Neal Patel
    Kian Bichoupan
    Lawrence Ku
    Rachana Yalamanchili
    Alyson Harty
    Donald Gardenier
    Michel Ng
    David Motamed
    Viktoriya Khaitova
    Nancy Bach
    Charissa Chang
    Priya Grewal
    Meena Bansal
    Ritu Agarwal
    Lawrence Liu
    Gene Im
    Jennifer Leong
    Leona Kim-Schluger
    Joseph Odin
    Jawad Ahmad
    Scott Friedman
    Douglas Dieterich
    Thomas Schiano
    Ponni Perumalswami
    Andrea Branch
    [J]. World Journal of Gastroenterology, 2016, 22 (09) : 2844 - 2854
  • [3] Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
    Patel, Neal
    Bichoupan, Kian
    Ku, Lawrence
    Yalamanchili, Rachana
    Harty, Alyson
    Gardenier, Donald
    Ng, Michel
    Motamed, David
    Khaitova, Viktoriya
    Bach, Nancy
    Chang, Charissa
    Grewal, Priya
    Bansal, Meena
    Agarwal, Ritu
    Liu, Lawrence
    Im, Gene
    Leong, Jennifer
    Kim-Schluger, Leona
    Odin, Joseph
    Ahmad, Jawad
    Friedman, Scott
    Dieterich, Douglas
    Schiano, Thomas
    Perumalswami, Ponni
    Branch, Andrea
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (09) : 2844 - 2854
  • [4] Risk of incident liver cancer following HCV treatment with sofosbuvir-containing regimens
    Chokkalingam, Anand P.
    Singer, Amanda W.
    Osinusi, Anu O.
    Brainard, Diana M.
    Telep, Laura
    [J]. HEPATOLOGY, 2016, 64 : 365A - 366A
  • [5] Assessment of risk of acute kidney injury associated with exposure to sofosbuvir-containing HCV treatment regimens and HCV infection
    Telep, Laura
    Brown, Andrea
    Brainard, Diana M.
    Chokkalingam, Anand P.
    [J]. HEPATOLOGY, 2016, 64 : 380A - 380A
  • [6] Staging of hepatic fibrosis by liver elastometry (fibroscan) in recurrent HCV infection in liver transplant recipients
    Corradi, F.
    Piscaglia, E.
    Tame, R.
    Colecchia, A.
    Andreone, P.
    D'Errico-Grigioni, A.
    Vasuri, E.
    Venturi, A.
    Lanzi, A.
    Boni, P.
    Bolondi, L.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S59 - S59
  • [7] Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin
    Pillai, A. A.
    Maheshwari, R.
    Vora, R.
    Norvell, J. P.
    Ford, R.
    Parekh, S.
    Cheng, N.
    Patel, A.
    Young, N.
    Spivey, J. R.
    Mgbemena, O.
    Wedd, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1427 - 1432
  • [8] Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection
    Iwai, A.
    Marusawa, H.
    Takada, Y.
    Egawa, H.
    Ikeda, K.
    Nabeshima, M.
    Uemoto, S.
    Chiba, T.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2006, 13 (08) : 523 - 531
  • [9] Sofosbuvir-containing regimens are better than NS3 protease inhibitors-containing regimes for genotype 1b hepatitis C in liver transplant recipients
    Khubutia, M.
    Syutkin, V.
    Salienko, A.
    Novruzbekov, M.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 49 - 49
  • [10] On Treatment HCV RNA as a Predictor of Virologic Response in Sofosbuvir-Containing Regimens for Genotype 2/3 HCV Infection: Analysis of the FISSION, POSITRON, and FUSION Studies
    Wyles, David L.
    Nelson, David R.
    Swain, Mark G.
    Gish, Robert G.
    Ma, Julie
    McNally, John
    Brainard, Diana M.
    Symonds, William T.
    McHutchison, John G.
    Bernstein, David E.
    Thompson, Alexander J.
    Mangia, Alessandra
    Jacobson, Ira M.
    [J]. HEPATOLOGY, 2013, 58 : 750A - 750A